p19Arf suppresses growth, progression, and metastasis of Hras-driven carcinomas through p53-dependent and -independent pathways. by Karen S Kelly-Spratt, Kay E Gurley, Yutaka Yasui, Christopher J Kemp

Get full text

Whole Slide Image Analysis System for Quantification of Liver Fibrosis by Tokiya Abe, Yuri Murakami, Masahiro Yamguchi, Yoshiko Yamashita, Tomoharu Kiyuna, Ken Yamazaki, Akinori Hashiguchi, Yutaka Yasui, Masayuki Kurosaki, Namiki Izumi, Michiie Sakamoto

Get full text

The impact of background liver disease on the long-term prognosis of very-early-stage HCC after ablation therapy. by Kenta Takaura, Masayuki Kurosaki, Kento Inada, Sakura Kirino, Kouji Yamashita, Tomohiro Muto, Leona Osawa, Shuhei Sekiguchi, Yuka Hayakawa, Mayu Higuchi, Shun Kaneko, Chiaki Maeyashiki, Nobuharu Tamaki, Yutaka Yasui, Jun Itakura, Kaoru Tsuchiya, Hiroyuki Nakanishi, Yuka Takahashi, Namiki Izumi

Get full text

Serum FGF21 as a predictor of response to atezolizumab and bevacizumab in HCC by Risako Kohya, Goki Suda, Masatsugu Ohara, Shunichi Hosoda, Takuya Sho, Makoto Chuma, Atsumasa Komori, Yuki Kugiyama, Yutaka Yasui, Kaoru Tsuchiya, Masayuki Kurosaki, Joji Tani, Shun Kaneko, Mina Nakagawa, Yasuhiro Asahina, Shinya Maekawa, Nobuyuki Enomoto, Yoshiya Yamamoto, Masaru Baba, Ren Yamada, Takashi Sasaki, Tomoka Yoda, Sonoe Yoshida, Qingjie Fu, Zijian Yang, Osamu Maehara, Shunsuke Ohnishi, Yoshimasa Tokuchi, Takashi Kitagataya, Naoki Kawagishi, Masato Nakai, Mitsuteru Natsuizaka, Koji Ogawa, Naoya Sakamoto

Get full text